
Clovis Oncology: Forging A Fresh Perspective (CLVS)
CasarsaGuru/E+ via Getty Images Clovis Oncology (NASDAQ:CLVS) continues to report lackluster earnings which have destroyed the share price and investor sentiment. At one point, Clovis had a promising outlook and was considered a prime acquisition […]